| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT03975829 Pediatric Long-Term Follow-up and Rollover Study |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-12 | NCT03374657 A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis… |
Trial completed |
| 2026-06-12 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-12 | NCT06665256 Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
Enrollment reduced: 123 -> 21 participants |
| 2026-06-12 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Primary completion pushed: 2027-03-03 -> 2029-01-10 |
| 2026-06-12 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Completion pushed: 2027-03-31 -> 2030-09-18 |
| 2026-06-11 | NCT07630961 Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in… |
Recruitment opened |
| 2026-06-11 | NCT07517263 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate… |
Trial sites expanded: 559 -> 618 locations |
| 2026-06-11 | NCT05939414 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… |
Trial sites expanded: 144 -> 147 locations |
| 2026-06-10 | NCT07517250 A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease… |
date change Primary completion moved earlier: 2027-03-03 -> 2026-12-03 |
| 2026-06-10 | NCT07517250 A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease… |
date change Completion moved earlier: 2027-03-03 -> 2026-12-03 |
| 2026-06-10 | NCT07468071 Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit… |
Recruitment opened |
| 2026-06-09 | NCT07039422 Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody… |
Trial sites expanded: 18 -> 22 locations |
| 2026-06-09 | NCT07594587 A Study of Ruxolitinib in Patients With Graft-Versus Host Disease |
Recruitment opened |
| 2026-06-09 | NCT07594587 A Study of Ruxolitinib in Patients With Graft-Versus Host Disease |
date change Primary completion pushed: 2030-03-15 -> 2030-05-15 |
| 2026-06-09 | NCT07594587 A Study of Ruxolitinib in Patients With Graft-Versus Host Disease |
date change Completion pushed: 2030-03-15 -> 2030-05-15 |
| 2026-06-09 | NCT07326709 A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants… |
Trial sites expanded: 13 -> 20 locations |
| 2026-06-09 | NCT06824103 Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With… |
date change Primary completion moved earlier: 2029-11-29 -> 2029-05-10 |
| 2026-06-09 | NCT07422610 Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies… |
Trial sites expanded: 2 -> 5 locations |
| 2026-06-09 | NCT07235046 A Study of DII235 in Adults With Elevated Lipoprotein(a) |
date change Primary completion moved earlier: 2027-09-08 -> 2027-04-26 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07642557 Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT) | Not Yet Recruiting | |
| 2026-06-09 | NCT07635316 A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor… | Not Yet Recruiting | |
| 2026-06-05 | NCT07630961 Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in… | Phase 1 | Recruiting |
| 2026-06-04 | NCT07625306 Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and… | Phase 3 | Not Yet Recruiting |
| 2026-06-04 | NCT07626281 Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New… | Phase 1 | Not Yet Recruiting |
| 2026-06-02 | NCT07621809 Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus… | Phase 3 | Not Yet Recruiting |
| 2026-05-27 | NCT07610278 A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in… | Phase 2 | Not Yet Recruiting |
| 2026-05-22 | NCT07604324 A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and… | Phase 1 | Recruiting |
| 2026-05-22 | NCT07604571 Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2… | Phase 1 | Recruiting |
| 2026-05-20 | NCT07598422 A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06501443 | LATAM LOWERS LDL-C | Hypercholesterolaemia | Recruiting |
| NCT07034690 | Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in… | Atherosclerotic Cardiovascular Disease | Recruiting |
| NCT06733922 | ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS | Relapsing Remitting Multiple Sclerosis (RRMS) | Recruiting |
| NCT04480853 | Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing… | Multiple Sclerosis | Recruiting |
| NCT06372925 | Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute… | Plaque, Atherosclerotic | Recruiting |
| NCT04638647 | Secukinumab Open Label Roll-over Extension Protocol | Autoimmunity, Inflammation | Recruiting |
| NCT07489573 | Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to… | Hidradenitis Suppurativa (HS) | Recruiting |
| NCT05803941 | Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate… | Prostate Cancer | Recruiting |
| NCT04657822 | Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior… | Sickle Cell Disease | Recruiting |
| NCT06824103 | Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With… | Graft vs. Host Disease | Recruiting |
| NCT03340506 | Dabrafenib and/or Trametinib Rollover Study | Melanoma | Recruiting |
| NCT04877522 | Asciminib Roll-over Study | Chronic Myelogenous Leukemia | Recruiting |
| NCT06444113 | Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of… | Multiple Sclerosis | Active, Not Recruiting |
| NCT02386800 | CINC424A2X01B Rollover Protocol | Primary Myelofibrosis | Active, Not Recruiting |
| NCT05090371 | A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After… | Relapsing-Remitting Multiple Sclerosis | Active, Not Recruiting |
| NCT06941792 | Inclisiran Effectiveness in China: a Pragmatic Randomized Trial | Coronary Heart Disease | Active, Not Recruiting |
| NCT07448610 | ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants… | Spinal Muscular Atrophy | Not Yet Recruiting |
| NCT05622708 | A Study of Secukinumab to Evaluate Maintenance of Response in Participants With… | Non-radiographic Axial Spondyloarthritis | Active, Not Recruiting |
| NCT02584933 | Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib… | ALK Positive Malignancies | Active, Not Recruiting |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | Diffuse Astrocytoma | Active, Not Recruiting |
| NCT05161195 | Roll-over Study to Allow Continued Access to Ribociclib | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT05252585 | A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous… | Renal Angiomyolipoma | Active, Not Recruiting |
| Phase 3 | |||
| NCT05335876 | Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in… | Spinal Muscular Atrophy (SMA) | Recruiting |
| NCT06597006 | Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With… | Familial Hypercholesterolemia - Homozygous | Recruiting |
| NCT06711887 | Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study… | Lupus Nephritis | Recruiting |